Increasing incidence of mumps in Scotland: Options for reducing transmission

Journal of Clinical Virology

Volumn 35, Issue 2, 2006, Pages 121-129

  Donaghy, Martin ^a   Cameron, J Claire ^a   Friederichs, Vera ^a,b  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Disease outbreak prevention and control; Measles mumps rubella vaccine; Mumps

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; ASEPTIC MENINGITIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; ENCEPHALITIS; HEARING IMPAIRMENT; HERD IMMUNITY; HUMAN; IMMUNIZATION; INCIDENCE; MAJOR CLINICAL STUDY; MORBIDITY; MUMPS; ORCHITIS; PANCREATITIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SOCIAL BEHAVIOR; UNITED KINGDOM; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; INFANT; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; MUMPS VIRUS; SCOTLAND; VACCINATION;

EID: 30144432331     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2005.09.009     Document Type: Review

References (25)

1. D.R. Arday, D.D. Kanjarpane, and P.W. Kelley Mumps in the US Army 1980-1986: should recruits be immunized? Am J Public Health 79 1989 471 474
2. J.C. Bramley, L.A. Wallace, S. Ahmed, R. Duff, W.F. Carman, and S.O. Cameron Universal hepatitis B vaccination of UK adolescents: a feasibility and acceptability study Commun Dis Public Health 5 2002 318 320
3. K. Broliden, E.R. Abreu, M. Arneborn, and M. Bottiger Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme Vaccine 16 1998 323 327
4. Chief Medical Officer. Mumps outbreaks in Scotland: offer of MMR to high-risk individuals in high risk settings. Scottish Executive, Edinburgh 2004.
5. J. Chin Control of Communicable Diseases Manual 2000 American Public Health Association Washington
6. I. Davidkin, M. Valle, and I. Julkunen Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination: a 9-year follow-up Vaccine 13 1995 1617 1622
7. Department of Health, Welsh Office, Scottish Office Department of Health, DHSS (Northern Ireland). Immunisation against Infectious Disease, HMSO, London. 1996.
8. C.P. Farrington, and M.N. Kanaan Estimation of the basic reproduction number for infectious diseases from age-stratified serological survey data Appl Stat 50 2001 251 292
9. P.E.M. Fine Community Immunity S.A. Plotkin WA. Orenstein Vaccines 2004 Saunders Philadelphia
10. N.S. Galbraith, S.E.J. Young, J.J. Pusey, D.L. Crombie, and J.P. Sparks Mumps surveillance in England and Wales 1962-1981 Lancet 1 1984 91 94
11. D. Germann, and L. Matter Raising the immunization rate in medical students against measles, mumps and rubella at the University of Berne NHS Centre for Reviews and Dissemination 1999 http://nhscrd.york.ac.uk/online/ nhseed/19990822.htm
12. R. Hall, and H. Richards Hearing loss due to mumps Arch Dis Child 62 1987 189 191
13. Information Services Division. Provision of Healthcare. In: Scottish Health Services Costs 2002/2003. Edinburgh: ISD 2004.
14. Meningococcal C Immunisation Programme Implementation Group. Meningococcal Group C Immunisation Programme in Scotland: Final Report 2001. (http://www.show.scot.nhs.uk/scieh/documents/MenC_Prog_Scot.pdf).
15. Mooney JD, Donaghy M. Uptake of group C meningococcal conjugate vaccine in a sample population of 20-24 year olds in Scotland. SCIEH Weekly Report 2004; 38:66-7.
16. A. Netten, J. Dennett, and J. Knight Unit Costs of Health and Social Care 1999 PSSRU, University of Kent Canterbury
17. S.A. Plotkin Mumps Vaccine S.A. Plotkin WA. Orenstein Vaccines 2004 W.B. Saunders Philadelphia
18. R.N. Pugh, B. Akinosi, S. Pooransingh, J. Kumar, S. Grant, and E. Livesley An outbreak of mumps in the metropolitan area of Walsall, UK Int J Infect Dis 6 2002 283 287
19. E.A. Reaney, V.K. Tohani, M.J. Devine, R.D. Smithson, and B. Smyth Mumps outbreak among young people in Northern Ireland Commun Dis Public Health 4 2001 311 315
20. D.M. Sosin, S.L. Cochi, R.A. Gunn, C.E. Jennings, and S.R. Preblud Changing epidemiology or mumps and its impact on university campuses Pediatrics 84 1989 779 784
21. B.H. Stover, G. Adams, C.A. Kuebler, K.M. Cost, and G.P. Rabalais Measles-mumps-rubella immunization of susceptible hospital employees during a community measles outbreak: cost-effectiveness and protective efficacy Infect Control Hosp Epidemiol 15 1994 18 21
22. F.P.L. van Loon, S.J. Holmes, B.I. Sirotkin, W.W. Williams, S.L. Cochi, and S.C. Hadler Mumps Surveillance - United States 1988-1993 MMWR Morb Mortal Wkly Rep 44 1995 1 14
23. L.A. Wallace, D. Young, A. Brown, J.C. Cameron, S. Ahmed, and R. Duff Costs of running a universal adolescent Hepatitis B vaccination programme Vaccine 23 2005 5624 5631
24. H. Wechner, R.M.L. Morris, D. Hunt, L. Jin, and J. Stuart A secondary school outbreak of mumps following the childhood immunization programme in England and Wales Epidemiol Infect 124 2000 131 136
25. World Health Organisation. Mumps virus vaccines. WHO position paper. Wkly Epidemiol Rec 2001; 76:345-56.